Poor Digestion in Alzheimer’s Microglia: Is Beclin to Blame?
Without the protein beclin 1, rapacious microglia choke on amyloid β.
6337 RESULTS
Sort By:
Without the protein beclin 1, rapacious microglia choke on amyloid β.
As heat shock protein and co-chaperone team up to shield tau from degradation, they create toxic oligomers.
New research connects extracellular Aβ to intracellular kinases that mediate its toxicity.
Older people improved memory and attention after playing a challenging video game, supporting the idea that multitasking could have benefits for cognition.
New imaging data suggests degeneration of the fornix could help identify seniors on the verge of cognitive decline.
A new study supports the idea that non-motor symptoms of Parkinson's disease may aid earlier diagnosis.
Amyloid fibrils seeded by Alzheimer’s brain extracts indicate that Aβ forms specific strains in different individuals.
Cerebrospinal Fluid Tau Climbs in Aβ Mouse Models Coverage Denial For Amyloid Scans Riles Alzheimer’s Community Pooled GWAS Reveals New Alzheimer’s Genes and Pathways Are Subtle Memory Concerns a Sign of Future Dementia? Clinical Trials Roundup: Four Hits
Experimental α7 Agonist Meets Cognitive and Clinical Endpoints New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity Q&A With Roche’s CNS Leader Luca Santarelli When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion? Wave of Ne
Madrid: ICAD Conference Draws to a Close Madrid: BACE Found to Have Big Job in Wrapping Motoneurons Madrid: Why Do People Drop Out of Trials? Madrid: Stressed Brain—SNP Carriers Can Have Cake and Eat It Madrid: BACE News Roundup, Part 1 Madrid: BACE News
Philadelphia: All Eyes on PIB Imaging—Is It Coming Along? Philadelphia: All Is Not Well with the Statin Story Philadelphia: Can a Shrinking Brain Be Good for You? Philadelphia: Dementia Types Just Won’t Fit into Little Boxes Philadelphia: Diagnosis Light—
Stockholm: Visualizing Amyloid Biggest Draw at Imaging Symposium, Consensus Sought on Validation Stockholm: Chlamydia Triggers Amyloid Plaques in Mice Stockholm: Aph-1 and Pen-2: New Names in the Presenilin Debate Complete the Complex? Stockholm: Clusteri
Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments Washington: Shaking Up AD Treatment with Ketone Bodies Washington: Site-to-Site Differences Delay Result of Alzhemed Trial Washington: γ-secretase Inhibitor Survived Phase 2, Moving to
Chicago: Studies Probe Diminishing Placebo Decline, Part 1 Chicago: Studies Probe Diminishing Placebo Decline, Part 2 Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1 Chicago: The Ph
Vienna: New Genes, Anyone? ICAD Saves Best for Last Vienna: In Genetics, Bigger Is Better—Data Sharing Nets Three New Hits Vienna: Can a D-Peptide Turn Tiger Into Pussycat? Vienna: New Shoot Among Ashes of Drug Trials Vienna: New Tack to See Amyloid Oligo